Histone Deacetylase(HDAC) Inhibitors Market Report

Histone Deacetylase(HDAC) Inhibitors Market - Global Professional Analysis and Forecast to 2026

  • POSTDATE：Jan 07, 2020
  • PAGES：165
  • REPORT CODE：GMM426833
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The worldwide Histone Deacetylase(HDAC) Inhibitors market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 6.1% during the forecast period.

    This report presents the market size and development trends by detailing the Histone Deacetylase(HDAC) Inhibitors market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Histone Deacetylase(HDAC) Inhibitors market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Histone Deacetylase(HDAC) Inhibitors industry and will help you to build a panoramic view of the industrial development.

    Histone Deacetylase(HDAC) Inhibitors Market, By Type:

    • Hydroxamic Acids

    • Cyclic Tetrapeptides

    • Benzamides

    • Electrophilic Ketones

    • Aliphatic Acid

    Histone Deacetylase(HDAC) Inhibitors Market, By Application:

    • Psychiatry and Neurology

    • Cancer Treatment

    • HIV

    • Others

    Some of the leading players are as follows:

    • Gloucester Pharmaceuticals

    • SpeBio

    • Pharmacyclics

    • Quimatryx

    • Onyx

    • Ventana Medical Systems

    • Signal Rx

    • Karus Therapeutics

    • Mirati Therapeutics

    • TetraLogic Pharmaceuticals

    • Spectrum Pharmaceuticals

    Geographically, Major regions are analyzed in details are as follows:

    • North America

    • Europe

    • Asia Pacific

    • Latin America

    • Middle East & Africa

  • Table of Contents

    1 Methodology and Scope

    • 1.1 Market Segmentation & Scope

      • 1.1.1 Technology Type

      • 1.1.2 Product

      • 1.1.3 Application

      • 1.1.4 Regional scope

      • 1.1.5 Estimates and forecast timeline

    • 1.2 Research Methodology

    • 1.3 Information Procurement

      • 1.3.1 Purchased database

      • 1.3.2 Internal database

      • 1.3.3 Secondary sources

      • 1.3.4 Primary research

      • 1.3.5 Details of primary research

    • 1.4 Information or Data Analysis

      • 1.4.1 Data analysis models

    • 1.5 Market Formulation & Validation

    • 1.6 Model Details

      • 1.6.1 Commodity flow analysis

      • 1.6.2 Volume price analysis

    • 1.7 List of Secondary Sources

    • 1.8 List of Abbreviations

    2 Executive Summary

    • 2.1 Market Outlook

    • 2.2 Segment Outlook

    3 Market Variables, Trends, & Scope

    • 3.1 Market Lineage Outlook

    • 3.1.1 Parent market outlook

      • 3.1.2 Ancillary market outlook

    • 3.2 Market Segmentation

      • 3.2.1 Analysis

    • 3.3 Market Dynamics

      • 3.3.1 Market driver analysis

      • 3.3.2 Market restraint analysis

      • 3.3.3 Industry opportunities

    • 3.4 Penetration & Growth Prospect Mapping

      • 3.4.1 Penetration & growth prospect mapping analysis

    • 3.5 Business Environment Analysis Tools

      • 3.5.1 Porter's five forces analysis

      • 3.5.2 PESTLE analysis

      • 3.5.3 Major deals & strategic alliances analysis

    4 Histone Deacetylase(HDAC) Inhibitors Market: Technology Type Analysis

    • 4.1 Histone Deacetylase(HDAC) Inhibitors Technology Type Market Share Analysis, 2018 & 2026

    • 4.2 Histone Deacetylase(HDAC) Inhibitors Technology Type Market: Segment Dashboard

    • 4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment

      • 4.3.1 Hydroxamic Acids

      • 4.3.2 Cyclic Tetrapeptides

      • 4.3.3 Benzamides

      • 4.3.4 Electrophilic Ketones

      • 4.3.5 Aliphatic Acid

    5 Histone Deacetylase(HDAC) Inhibitors Market: Product Analysis

    • 5.1 Histone Deacetylase(HDAC) Inhibitors Product Market Share Analysis, 2018 & 2026

    • 5.2 Histone Deacetylase(HDAC) Inhibitors Product Market: Segment Dashboard

    • 5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment

    6 Histone Deacetylase(HDAC) Inhibitors Market: Application Analysis

    • 6.1 Histone Deacetylase(HDAC) Inhibitors Application Market Share Analysis, 2018 & 2026

    • 6.2 Histone Deacetylase(HDAC) Inhibitors Application Market: Segment Dashboard

    • 6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment

      • 6.3.1 Psychiatry and Neurology

      • 6.3.2 Cancer Treatment

      • 6.3.3 HIV

      • 6.3.4 Others

    7 Histone Deacetylase(HDAC) Inhibitors Market: Regional Analysis

    • 7.1 Histone Deacetylase(HDAC) Inhibitors Regional Market Share Analysis, 2018 & 2026

    • 7.2 Histone Deacetylase(HDAC) Inhibitors Regional Market: Segment Dashboard

    • 7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)

    • 7.4 List of Players at Regional Level

      • 7.4.1 North America

      • 7.4.2 Europe

      • 7.4.3 Asia Pacific

    • 7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)

      • 7.5.1 North America

      • 7.5.2 Europe

      • 7.5.3 Asia Pacific

      • 7.5.4 Latin America

      • 7.5.5 MEA

    • 7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026

      • 7.6.1 North America

      • 7.6.2 Europe

      • 7.6.3 Asia Pacific

      • 7.6.4 Latin America

      • 7.6.5 Middle East & Africa

    8 Competitive Analysis

    • 8.1 Recent Developments & Impact Analysis, by Key Market Participants

    • 8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)

    • 8.3 Vendor Landscape

      • 8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)

    9 Company Profiles

    • 9.1 Gloucester Pharmaceuticals

      • 9.1.1 Gloucester Pharmaceuticals Company overview

      • 9.1.2 Financial performance

      • 9.1.3 Product benchmarking

      • 9.1.4 Strategic initiatives

      • 9.1.5 SWOT analysis

    • 9.2 SpeBio

      • 9.2.1 SpeBio Company overview

      • 9.2.2 Financial performance

      • 9.2.3 Product benchmarking

      • 9.2.4 Strategic initiatives

      • 9.2.5 SWOT analysis

    • 9.3 Pharmacyclics

      • 9.3.1 Pharmacyclics Company overview

      • 9.3.2 Financial performance

      • 9.3.3 Product benchmarking

      • 9.3.4 Strategic initiatives

      • 9.3.5 SWOT analysis

    • 9.4 Quimatryx

      • 9.4.1 Quimatryx Company overview

      • 9.4.2 Financial performance

      • 9.4.3 Product benchmarking

      • 9.4.4 Strategic initiatives

      • 9.4.5 SWOT analysis

    • 9.5 Onyx

      • 9.5.1 Onyx Company overview

      • 9.5.2 Financial performance

      • 9.5.3 Product benchmarking

      • 9.5.4 Strategic initiatives

      • 9.5.5 SWOT analysis

    • 9.6 Ventana Medical Systems

      • 9.6.1 Ventana Medical Systems Company overview

      • 9.6.2 Financial performance

      • 9.6.3 Product benchmarking

      • 9.6.4 Strategic initiatives

      • 9.6.5 SWOT analysis

    • 9.7 Signal Rx

      • 9.7.1 Signal Rx Company overview

      • 9.7.2 Financial performance

      • 9.7.3 Product benchmarking

      • 9.7.4 Strategic initiatives

      • 9.7.5 SWOT analysis

    • 9.8 Karus Therapeutics

      • 9.8.1 Karus Therapeutics Company overview

      • 9.8.2 Financial performance

      • 9.8.3 Product benchmarking

      • 9.8.4 Strategic initiatives

      • 9.8.5 SWOT analysis

    • 9.9 Mirati Therapeutics

      • 9.9.1 Mirati Therapeutics Company overview

      • 9.9.2 Financial performance

      • 9.9.3 Product benchmarking

      • 9.9.4 Strategic initiatives

      • 9.9.5 SWOT analysis

    • 9.10 TetraLogic Pharmaceuticals

      • 9.10.1 TetraLogic Pharmaceuticals Company overview

      • 9.10.2 Financial performance

      • 9.10.3 Product benchmarking

      • 9.10.4 Strategic initiatives

      • 9.10.5 SWOT analysis

    • 9.11 Spectrum Pharmaceuticals

      • 9.11.1 Spectrum Pharmaceuticals Company overview

      • 9.11.2 Financial performance

      • 9.11.3 Product benchmarking

      • 9.11.4 Strategic initiatives

      • 9.11.5 SWOT analysis

     

    The List of Tables and Figures (Totals 70 Figures and 148 Tables)

    • Figure Hydroxamic Acids Histone Deacetylase(HDAC) Inhibitors market, 2015 - 2026 (USD Million)

    • Figure Cyclic Tetrapeptides Histone Deacetylase(HDAC) Inhibitors market, 2015 - 2026 (USD Million)

    • Figure Benzamides Histone Deacetylase(HDAC) Inhibitors market, 2015 - 2026 (USD Million)

    • Figure Electrophilic Ketones Histone Deacetylase(HDAC) Inhibitors market, 2015 - 2026 (USD Million)

    • Figure Aliphatic Acid Histone Deacetylase(HDAC) Inhibitors market, 2015 - 2026 (USD Million)

    • Figure Psychiatry and Neurology market, 2015 - 2026 (USD Million)

    • Figure Cancer Treatment market, 2015 - 2026 (USD Million)

    • Figure HIV market, 2015 - 2026 (USD Million)

    • Figure Others market, 2015 - 2026 (USD Million)

    • Table List of players in North America

    • Table List of players in Europe

    • Table List of players in Asia Pacific

    • Table SWOT analysis

    • Table North America Histone Deacetylase(HDAC) Inhibitors market, by country, 2015 - 2026 (USD Million)

    • Table North America Histone Deacetylase(HDAC) Inhibitors market, by type, 2015 - 2026 (USD Million)

    • Table North America Histone Deacetylase(HDAC) Inhibitors market, by product, 2015 - 2026 (USD Million)

    • Table North America Histone Deacetylase(HDAC) Inhibitors market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table U.S. Histone Deacetylase(HDAC) Inhibitors market, by type, 2015 - 2026 (USD Million)

    • Table U.S. Histone Deacetylase(HDAC) Inhibitors market, by product, 2015 - 2026 (USD Million)

    • Table U.S. Histone Deacetylase(HDAC) Inhibitors market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Canada Histone Deacetylase(HDAC) Inhibitors market, by type, 2015 - 2026 (USD Million)

    • Table Canada Histone Deacetylase(HDAC) Inhibitors market, by product, 2015 - 2026 (USD Million)

    • Table Canada Histone Deacetylase(HDAC) Inhibitors market, by application, 2015 - 2026 (USD Million)

    • Table Europe Histone Deacetylase(HDAC) Inhibitors market, by country, 2015 - 2026 (USD Million)

    • Table Europe Histone Deacetylase(HDAC) Inhibitors market, by type, 2015 - 2026 (USD Million)

    • Table Europe Histone Deacetylase(HDAC) Inhibitors market, by product, 2015 - 2026 (USD Million)

    • Table Europe Histone Deacetylase(HDAC) Inhibitors market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table U.K. Histone Deacetylase(HDAC) Inhibitors market, by type, 2015 - 2026 (USD Million)

    • Table U.K. Histone Deacetylase(HDAC) Inhibitors market, by product, 2015 - 2026 (USD Million)

    • Table U.K. Histone Deacetylase(HDAC) Inhibitors market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Germany Histone Deacetylase(HDAC) Inhibitors market, by type, 2015 - 2026 (USD Million)

    • Table Germany Histone Deacetylase(HDAC) Inhibitors market, by product, 2015 - 2026 (USD Million)

    • Table Germany Histone Deacetylase(HDAC) Inhibitors market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table France Histone Deacetylase(HDAC) Inhibitors market, by type, 2015 - 2026 (USD Million)

    • Table France Histone Deacetylase(HDAC) Inhibitors market, by product, 2015 - 2026 (USD Million)

    • Table France Histone Deacetylase(HDAC) Inhibitors market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Italy Histone Deacetylase(HDAC) Inhibitors market, by type, 2015 - 2026 (USD Million)

    • Table Italy Histone Deacetylase(HDAC) Inhibitors market, by product, 2015 - 2026 (USD Million)

    • Table Italy Histone Deacetylase(HDAC) Inhibitors market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Spain Histone Deacetylase(HDAC) Inhibitors market, by type, 2015 - 2026 (USD Million)

    • Table Spain Histone Deacetylase(HDAC) Inhibitors market, by product, 2015 - 2026 (USD Million)

    • Table Spain Histone Deacetylase(HDAC) Inhibitors market, by application, 2015 - 2026 (USD Million)

    • Table Asia Pacific Histone Deacetylase(HDAC) Inhibitors market, by country, 2015 - 2026 (USD Million)

    • Table Asia Pacific Histone Deacetylase(HDAC) Inhibitors market, by type, 2015 - 2026 (USD Million)

    • Table Asia Pacific Histone Deacetylase(HDAC) Inhibitors market, by product, 2015 - 2026 (USD Million)

    • Table Asia Pacific Histone Deacetylase(HDAC) Inhibitors market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table China Histone Deacetylase(HDAC) Inhibitors market, by type, 2015 - 2026 (USD Million)

    • Table China Histone Deacetylase(HDAC) Inhibitors market, by product, 2015 - 2026 (USD Million)

    • Table China Histone Deacetylase(HDAC) Inhibitors market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Japan Histone Deacetylase(HDAC) Inhibitors market, by type, 2015 - 2026 (USD Million)

    • Table Japan Histone Deacetylase(HDAC) Inhibitors market, by product, 2015 - 2026 (USD Million)

    • Table Japan Histone Deacetylase(HDAC) Inhibitors market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table India Histone Deacetylase(HDAC) Inhibitors market, by type, 2015 - 2026 (USD Million)

    • Table India Histone Deacetylase(HDAC) Inhibitors market, by product, 2015 - 2026 (USD Million)

    • Table India Histone Deacetylase(HDAC) Inhibitors market, by application, 2015 - 2026 (USD Million)

    • Table Latin America Histone Deacetylase(HDAC) Inhibitors market, by country, 2015 - 2026 (USD Million)

    • Table Latin America Histone Deacetylase(HDAC) Inhibitors market, by type, 2015 - 2026 (USD Million)

    • Table Latin America Histone Deacetylase(HDAC) Inhibitors market, by product, 2015 - 2026 (USD Million)

    • Table Latin America Histone Deacetylase(HDAC) Inhibitors market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Brazil Histone Deacetylase(HDAC) Inhibitors market, by type, 2015 - 2026 (USD Million)

    • Table Brazil Histone Deacetylase(HDAC) Inhibitors market, by product, 2015 - 2026 (USD Million)

    • Table Brazil Histone Deacetylase(HDAC) Inhibitors market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Mexico Histone Deacetylase(HDAC) Inhibitors market, by type, 2015 - 2026 (USD Million)

    • Table Mexico Histone Deacetylase(HDAC) Inhibitors market, by product, 2015 - 2026 (USD Million)

    • Table Mexico Histone Deacetylase(HDAC) Inhibitors market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Argentina Histone Deacetylase(HDAC) Inhibitors market, by type, 2015 - 2026 (USD Million)

    • Table Argentina Histone Deacetylase(HDAC) Inhibitors market, by product, 2015 - 2026 (USD Million)

    • Table Argentina Histone Deacetylase(HDAC) Inhibitors market, by application, 2015 - 2026 (USD Million)

    • Table MEA Histone Deacetylase(HDAC) Inhibitors market, by country, 2015 - 2026 (USD Million)

    • Table MEA Histone Deacetylase(HDAC) Inhibitors market, by type, 2015 - 2026 (USD Million)

    • Table MEA Histone Deacetylase(HDAC) Inhibitors market, by product, 2015 - 2026 (USD Million)

    • Table MEA Histone Deacetylase(HDAC) Inhibitors market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table South Africa Histone Deacetylase(HDAC) Inhibitors market, by type, 2015 - 2026 (USD Million)

    • Table South Africa Histone Deacetylase(HDAC) Inhibitors market, by product, 2015 - 2026 (USD Million)

    • Table South Africa Histone Deacetylase(HDAC) Inhibitors market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Nigeria Histone Deacetylase(HDAC) Inhibitors market, by type, 2015 - 2026 (USD Million)

    • Table Nigeria Histone Deacetylase(HDAC) Inhibitors market, by product, 2015 - 2026 (USD Million)

    • Table Nigeria Histone Deacetylase(HDAC) Inhibitors market, by application, 2015 - 2026 (USD Million)

    • Table Recent Developments & Impact Analysis, by Key Market Participants

    • Table Recent Developments & Impact Analysis, by Key Market Participants

    • Table Company market position analysis

    • Table Company Profiles

    • Table Gloucester Pharmaceuticals Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table SpeBio Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Pharmacyclics Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Quimatryx Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Onyx Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Ventana Medical Systems Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Signal Rx Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Karus Therapeutics Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Mirati Therapeutics Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table TetraLogic Pharmaceuticals Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Spectrum Pharmaceuticals Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US